BioSpace News Archive

Hospital for Special Surgery (HSS), the world’s largest academic medical center focused on musculoskeletal health, today announced that Andrew D. Pearle, MD, will succeed Bryan T. Kelly, MD, as chief of the HSS Sports Medicine Institute.

Leading patient identification solutions provider underscores use of standards, proven technology and data governance as most promising path towards advancing patient matching efforts on a national scale

Lifestyle Delivery Systems Inc.,, announces that the farm managed by the Company’s wholly-owned subsidiary, Agrotech LLC, has planted 10,000 seeds on two acres of licensed outdoor cultivation in Sacramento, CA.

AFYX Therapeutics announced findings from the development of a novel Oral Lichen Planus Symptom Severity Measure as a tool used to assess patients’ symptom experience on a daily basis.

Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago.

Outcome shows a reduction in antibiotic days, shorter length of stay, shorter duration of mechanical ventilation, and fewer patients at risk for antibiotic resistance or C.difficile infection lead to incremental reduction of costs of 26 percent in sepsis and 17.7 percent in lower respiratory tract infection

CANTEL MEDICAL CORP. announced that Peter Clifford, Executive Vice President and Chief Operating Officer, will be presenting at the Jefferies 2019 Global Healthcare Conference at the Grand Hyatt, New York.

Medifast, Inc. announced that Dan Chard, Chief Executive Officer, and Tim Robinson, Chief Financial Officer, will present at the Baird 2019 Global Consumer, Technology & Services Conference on Thursday, June 6, 2019 in New York, NY.

BioSpecifics Technologies Corp. announced that the Executive Committee of its Board of Directors has authorized a stock repurchase program under which BioSpecifics is authorized to repurchase up to $4 million of its outstanding common stock.

TTS Pharma Limited, a UK company which is a vertically integrated supply chain manager in the cultivation, manufacturing and development of the emerging ethical cannabis market, announces that it has successfully closed a private equity investment totalling £10.3 million, on the basis of a two-tranche investment.